Prescription drug spending is one of the fastest growing cost components of modern health care systems. A UK based research group has developed Safe Therapeutic Economic Pharmaceutical Selection (STEPS) - a new tool for the rational selection of medication for formulary inclusion. They are seeking a licensing or commercial agreement.